• Introduced
    Jan 28, 2026
  • Passed House
    Feb 11, 2026
  • Passed Senate
    Feb 26, 2026
  • Became Law
HB 1169
South Dakota House Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
classify medetomidine as a Schedule III controlled substance and establish permissible uses.
Last Action See all actions
Senate • Feb 26, 2026: Do Pass, Passed YEAS: 32, NAYS: 0, S.J. 412

Summary

Comments on HB 1169

Tweets

Whip Lists

Sponsors
Votes
Actions
  • Feb 26, 2026 | Senate
    • Do Pass, Passed YEAS: 32, NAYS: 0, S.J. 412
  • Feb 25, 2026 | Senate
    • Health and Human Services Scheduled for hearing, S.J. 1
    • Health and Human Services Do Pass, Passed YEAS: 7, NAYS: 0, S.J. 21
    • Health and Human Services Certified uncontested, placed on consent, S.J. 21
  • Feb 12, 2026 | Senate
    • First read in Senate and referred to Health and Human Services, S.J. 260
  • Feb 11, 2026 | House
    • Do Pass, Passed YEAS: 63, NAYS: 3, H.J. 295
  • Feb 10, 2026 | House
    • Health and Human Services Scheduled for hearing
    • Health and Human Services Do Pass, Passed YEAS: 11, NAYS: 0
    • Health and Human Services Certified uncontested, placed on consent
  • Jan 28, 2026 | House
    • First read in House and referred to Health and Human Services, H.J. 163
Documents
Looks like we don't have any documents available at this moment.